Condition 1: Dysmenorrhea. Condition 2: Premenstrual Syndrome. Primary dysmenorrhea Premenstrual tension syndrome
Conditions
Interventions
Intervention 1: Intervention group: In the intervention group, oral oregano capsules will be used once a day from 7 days before menstruation to the first 3 days of menstruation. Intervention 2: Contro
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 35 Years
Inclusion criteria
Inclusion criteria: 1. Age 18 to 35 years. 2. Regular menstrual cycles. 3. Suffering from premenstrual syndrome and primary moderate to severe dysmenorrhea at the same time. 4. Being single. 5. Resident in the dormitory of Mashhad University of Medical Sciences. 6. Not taking certain drugs. 7. Not using alcohol or drugs and tobacco. 8. Not having depression, anxiety and extreme stress. 9. Lack of diet. 10. Not using medicinal and traditional treatments to reduce the symptoms of premenstrual syndrome and dysmenorrhea. 11. BMI less than 30. 12. Absence of specific medical disease. 13. Absence of known gynecological issues such as fibroids and endometriosis. 14. The absence of stressful events in the past 6 months. 15. Not engaging in sports professionally.
Exclusion criteria
Exclusion criteria: 1. Age 18 to 35 years. 2. Regular menstrual cycles. 3. Suffering from premenstrual syndrome and primary moderate to severe dysmenorrhea at the same time. 4. Being single. 5. Resident in the dormitory of Mashhad University of Medical Sciences. 6. Not taking certain drugs. 7. Not using alcohol or drugs and tobacco. 8. Not having depression, anxiety and extreme stress. 9. Lack of diet. 10. Not using medicinal and traditional treatments to reduce the symptoms of premenstrual syndrome and dysmenorrhea. 11. BMI less than 30. 12. Absence of specific medical disease. 13. Absence of known gynecological issues such as fibroids and endometriosis. 14. The absence of stressful events in the past 6 months. 15. Not engaging in sports professionally.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Average total score of premenstrual syndrome symptoms. Timepoint: Calculation of the average score of premenstrual syndrome symptoms at the beginning of the study (before the start of the intervention) and 1 and 2 months after the start of the intervention. Method of measurement: The mean total score of premenstrual syndrome symptoms will be evaluated by the Calendar of Premenstrual Events (COPE) form, as self-reported by the patients.;Average total score of severity and duration of primary dysmenorrhea. Timepoint: Calculation of the average score of severity and duration of dysmenorrhea at the beginning of the study (before the start of the intervention) and 1 and 2 months after the start of the intervention. Method of measurement: The mean total score of dysmenorrhea intensity by the visual pain scale (VAS) and the mean total score of pain duration by the scale COX menstrual scale will be investigated in the form of self-reporting by patients. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohaddeseh Borhaninasab
Mashhad University of Medical Sciences
Outcome results
None listed